7 Related NICE guidance

7 Related NICE guidance


Ambulight PDT for the treatment of non-melanoma skin cancer (2011) NICE medical technology guidance 6

Metastatic malignant disease of unknown primary origin in adults: diagnosis and management (2010) NICE guideline CG104

Improving outcomes for people with skin tumours including melanoma (2010) NICE cancer service guidance 8

Physical activity for children and young people (2009) NICE guideline PH17

Maternal and child nutrition (2008) NICE guideline PH11

Community engagement (2008) NICE guideline PH9

Physical activity and the environment (2008) NICE guideline PH8

Behaviour change: general approaches (2007) NICE guideline PH6

Referral guidelines for suspected cancer (2005) NICE guideline CG27

Under development

Melanoma (previously untreated unresectable stage III or IV) – ipilimumab in combination with dacarbazine. NICE technology appraisal (publication date to be confirmed)

Melanoma (stage III or IV) – ipilimumab. NICE technology appraisal (publication date to be confirmed)

  • National Institute for Health and Care Excellence (NICE)